BACKGROUND:Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid progression of disease and lack of biomarkers. Magnetic resonance imaging (MRI) has demonstrated its potential for detecting the pathological signature and tracking disease progression in ALS. However, the microstructural and molecular pathological substrate is poorly understood and generally defined histologically. One route to understanding and validating the pathophysiological correlates of MRI signal changes in ALS is to directly compare MRI to histology in post mortem human brains. RESULTS:The article delineates a universal whole brain sampling strategy of pathologica...
There is an increasing demand for non-invasive biomarkers that can reliably indicate the presence an...
International audienceBACKGROUND:Amyotrophic lateral sclerosis (ALS) is a rapidly progressive diseas...
Amyotrophic lateral sclerosis (ALS) is identified histologically by the deposition of phosphorylated...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneou...
Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegen...
Additional file 2. Structural MRI from thoracic to cervical region of the spinal cord from an ALS pa...
Additional file 3. Quantitative histological data for the primary motor cortex grey matter at the ha...
BACKGROUND AND PURPOSE: To date, damage of the cerebral cortex neurons in ALS was investigated by us...
Item does not contain fulltextOBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a fatal disease cha...
BACKGROUND AND PURPOSE: To date, damage of the cerebral cortex neurons in ALS was investigated by us...
BACKGROUND AND PURPOSE: The extensive application of advanced MR imaging techniques to the study of...
# The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Amyotr...
Amyotrophic lateral sclerosis (ALS) is characterized by progressive loss of upper and lower motor ne...
Brainstem pathology is a pathognomonic feature of ALS encompassing lower cranial nerve and descendin...
<div><p>Pathological and imaging data indicate that amyotrophic lateral sclerosis (ALS) is a multisy...
There is an increasing demand for non-invasive biomarkers that can reliably indicate the presence an...
International audienceBACKGROUND:Amyotrophic lateral sclerosis (ALS) is a rapidly progressive diseas...
Amyotrophic lateral sclerosis (ALS) is identified histologically by the deposition of phosphorylated...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneou...
Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous neurodegen...
Additional file 2. Structural MRI from thoracic to cervical region of the spinal cord from an ALS pa...
Additional file 3. Quantitative histological data for the primary motor cortex grey matter at the ha...
BACKGROUND AND PURPOSE: To date, damage of the cerebral cortex neurons in ALS was investigated by us...
Item does not contain fulltextOBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a fatal disease cha...
BACKGROUND AND PURPOSE: To date, damage of the cerebral cortex neurons in ALS was investigated by us...
BACKGROUND AND PURPOSE: The extensive application of advanced MR imaging techniques to the study of...
# The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Amyotr...
Amyotrophic lateral sclerosis (ALS) is characterized by progressive loss of upper and lower motor ne...
Brainstem pathology is a pathognomonic feature of ALS encompassing lower cranial nerve and descendin...
<div><p>Pathological and imaging data indicate that amyotrophic lateral sclerosis (ALS) is a multisy...
There is an increasing demand for non-invasive biomarkers that can reliably indicate the presence an...
International audienceBACKGROUND:Amyotrophic lateral sclerosis (ALS) is a rapidly progressive diseas...
Amyotrophic lateral sclerosis (ALS) is identified histologically by the deposition of phosphorylated...